0001209191-23-058349.txt : 20231212
0001209191-23-058349.hdr.sgml : 20231212
20231212180824
ACCESSION NUMBER: 0001209191-23-058349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elam Nevan C
CENTRAL INDEX KEY: 0001314773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 231482384
MAIL ADDRESS:
STREET 1: C/O NEKTAR THERAPEUTICS
STREET 2: 150 INDUSTRIAL ROAD
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 51285113796
MAIL ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-11
0
0001160308
Savara Inc
SVRA
0001314773
Elam Nevan C
ONE SUMMIT SQUARE,
1717 LANGHORNE NEWTOWN ROAD, SUITE 300
LANGHORNE
PA
19047
1
0
0
0
0
Common Stock
2023-12-11
4
M
0
10841
0.82
A
40085
D
Stock Option (Right to Buy)
0.82
2023-12-11
4
M
0
10841
0.00
D
2023-12-12
Common Stock
10841
0
D
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 12, 2014.
/s/ David Lowrance as attorney-in-fact for Nevan C. Elam
2023-12-12